Company profile

Dong-A ST

Diversified pharma

170900 · KRX · South Korea

Public Market Listing

170900KRX

KRX primary exchange listing

Live quotes, historical charts, and market capitalization for Dong-A ST are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(6 total)
6Total Assets
0Approved
3Phase 3 / Filed
3Phase 1–2 / Early
2Diseases
Quick filter:
Showing 6 of 6 assets
Target & Modality
DA5221-B1
Phase 3
DPP-4 / SGLT2 (combination)Small molecule
Type 2 Diabetes
Evogliptin(Suganon)
Phase 3
DPP-4Small molecule
Type 2 Diabetes
Udenafil(Zydena)No recent activity
Phase 3
PDE5Small molecule
Hypertension
DA-2811
Phase 2
SGLT2Small molecule
Type 2 Diabetes
DA-1241No recent activity
Phase 1
FXRSmall molecule
Type 2 Diabetes
DA-5218
Preclinical
DPP-4 / SGLT2 / AMPK pathway (triple)Small molecule
Type 2 Diabetes

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.